Lee Hong-Jen, He Jiabei, Chan Chia-Hsin
Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
Mol Cell Oncol. 2019 Jul 24;6(5):e1644599. doi: 10.1080/23723556.2019.1644599. eCollection 2019.
Our study uncovered that HectH9 drives glycolysis and tumor development by K63-linked ubiquitination of Hexokinase 2 (HK2). This mechanism is critical for HK2 localization to mitochondria for activating HK2's functions in glycolysis promotion and apoptosis inhibition, suggesting that targeting HectH9 is a new strategy to tackle metabolism-addicted tumors.
我们的研究发现,HectH9通过对己糖激酶2(HK2)进行K63连接的泛素化来驱动糖酵解和肿瘤发展。这一机制对于HK2定位于线粒体以激活其促进糖酵解和抑制凋亡的功能至关重要,这表明靶向HectH9是应对代谢成瘾性肿瘤的一种新策略。